CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
DOI 10.1055/s-0032-1309205
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Schmalfeldt, K Seck, AK Gonschior, H Gilet, M Heiss, M Hennig, M Moehler, E Schulze, P Wimberger, SL Parsons
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe04/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Fragestellung: Patients suffering from malignant ascites (MA) experience burdensome symptoms and an impaired quality of life (QoL) So far, therapeutic options are limited. The trifunctional antibody catumaxomab is approved for the treatment of MA. Its superiority over paracentesis including a positive trend in overall survival has been demonstrated in a pivotal study. The objective of this analysis was to compare as…
Zitieren
Zitierempfehlung
B Schmalfeldt, K Seck, AK Gonschior, H Gilet, M Heiss, M Hennig, M Moehler, E Schulze, P Wimberger, SL Parsons (2012) Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone. Geburtshilfe und Frauenheilkunde (04). https://doi.org/10.1055/s-0032-1309205
Mit CareLit weiterarbeiten